[{"abstract": "Johnson & Johnson has agreed to buy the medical equipment maker Synthes for $21.3 billion in cash and stock, in one of the biggest deals ever in the health care sector.", "web_url": "https://dealbook.nytimes.com/2011/04/27/j-j-announces-21-3-billion-deal-with-synthes/", "snippet": "Johnson & Johnson has agreed to buy the medical equipment maker Synthes for $21.3 billion in cash and stock, in one of the biggest deals ever in the health care sector.", "lead_paragraph": "Johnson & Johnson said on Wednesday that it had agreed to buy the medical equipment maker Synthes for $21.3 billion in cash and stock, in one of the biggest deals ever in the health care sector.", "source": "The New York Times", "multimedia": [], "headline": {"main": "J.&J. to Buy Synthes for $21.3 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Synthes Inc", "rank": 3, "major": "N"}], "pub_date": "2011-04-27T06:23:26+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/1e8e6eb6-d3be-5aaf-8939-16de646e65b9", "word_count": 501, "uri": "nyt://article/1e8e6eb6-d3be-5aaf-8939-16de646e65b9"}, {"abstract": "Johnson & Johnson is paying for the deal in stock and cash, rather than incurring a tax penalty for repatriating money from abroad.", "web_url": "https://dealbook.nytimes.com/2011/04/27/why-johnson-johnson-is-using-stock-to-buy-synthes/", "snippet": "Johnson & Johnson is paying for the deal in stock and cash, rather than incurring a tax penalty for repatriating money from abroad.", "lead_paragraph": "Johnson & Johnson\u2019s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Why Johnson & Johnson Is Using Stock to Buy Synthes", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Synthes Inc", "rank": 3, "major": "N"}], "pub_date": "2011-04-27T17:59:40+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/320e6040-dd1b-59f3-930c-9050f821c1fb", "word_count": 603, "uri": "nyt://article/320e6040-dd1b-59f3-930c-9050f821c1fb"}, {"abstract": "CNBC talks with Johnson & Johnson\u2019s chief executive, William C. Weldon, about the strategy behind the bid to buy Synthes.", "web_url": "https://dealbook.nytimes.com/2011/04/27/inside-johnson-johnsons-big-deal/", "snippet": "CNBC talks with Johnson & Johnson\u2019s chief executive, William C. Weldon, about the strategy behind the bid to buy Synthes.", "lead_paragraph": "CNBC talks with Johnson & Johnson\u2019s chief executive, William C. Weldon, about the strategy behind the bid to buy Synthes.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Inside Johnson & Johnson\u2019s Big Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Weldon, William C", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 2, "major": "N"}], "pub_date": "2011-04-27T19:47:39+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/938f402d-1ee7-55b5-94bb-ae281523e3c1", "word_count": 20, "uri": "nyt://article/938f402d-1ee7-55b5-94bb-ae281523e3c1"}, {"abstract": "The structure of Johnson & Johnson\u2019s deal with Synthes suggests that it has other deals in mind.", "web_url": "https://www.nytimes.com/2011/04/28/business/28views.html", "snippet": "The structure of Johnson & Johnson\u2019s deal with Synthes suggests that it has other deals in mind.", "lead_paragraph": "Johnson & Johnson may have more on its overseas shopping list. The health giant\u2019s $21.3 billion purchase of the Swiss-listed Synthes is its largest ever. A big deal seemed like a way for J.& J. to deploy its $28 billion of cash, largely trapped overseas. But as it turns out, it is paying mostly in stock.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2011/04/28/business/Views/Views-jumbo.jpg", "height": 973, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}], "headline": {"main": "J.&J. May Have More Acquisitions in Mind", "kicker": "Reuters Breakingviews", "content_kicker": null, "print_headline": "J.&J. May Have A Shopping List", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Johnson & Johnson", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "subject", "value": "Banking and Financial Institutions", "rank": 3, "major": "N"}, {"name": "subject", "value": "Financial Brokers", "rank": 4, "major": "N"}, {"name": "subject", "value": "Subprime Mortgage Crisis", "rank": 5, "major": "N"}], "pub_date": "2011-04-27T22:59:19+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By ROBERT CYRAN and ANTONY CURRIE", "person": [{"firstname": "Robert", "middlename": null, "lastname": "CYRAN", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "Antony", "middlename": null, "lastname": "CURRIE", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/8a2cee34-23c2-5dfe-9e2c-a5f7a4ca84c5", "word_count": 732, "uri": "nyt://article/8a2cee34-23c2-5dfe-9e2c-a5f7a4ca84c5"}]